Sadahiro Naka, Kazuhiro Ooe, Yoshifumi Shirakami, Kenta Kurimoto, Toshihiro Sakai, Kazuhiro Takahashi, Atsushi Toyoshima, Yang Wang, Hiromitsu Haba, Hiroki Kato, et al. Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial. EJNMMI radiopharmacy and chemistry. 2024. 9. 1. 29-29
Naoki Tsuchiya, Koichiro Kimura, Ukihide Tateishi, Tadashi Watabe, Koji Hatano, Motohide Uemura, Norio Nonomura, Akinobu Shimizu. Detection support of lesions in patients with prostate cancer using 18 F -PSMA 1007 PET/CT. International journal of computer assisted radiology and surgery. 2024. 19. 4. 613-623
Tadashi Watabe, Masao Namba, Sachiko Yanagida, Yoshihide Nakamura, Takahiro Yamada, Saori Tatsuno, Aritoshi Ri, Shuhei Yoshida, Kumiko Uyama, Seigo Kinuya, et al. Manual on the proper use of the 211At-labeled PSMA ligand ([211At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition). Annals of Nuclear Medicine. 2024
Ukihide Tateishi, Koichiro Kimura, Junichi Tsuchiya, Daisuke Kano, Tadashi Watabe, Norio Nonomura, Katsuhiko Saito, Kota Yokoyama, Ken Yamagiwa, Takuya Adachi, et al. Phase I/IIa trial of 18F-prostate specific membrane antigen (PSMA) 1007 PET/CT in healthy volunteers and prostate cancer patients. Japanese journal of clinical oncology. 2024. 54. 3. 282-291
Gaku Yamamichi, Taigo Kato, Tadashi Watabe, Koji Hatano, Motohide Uemura, Norio Nonomura. Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer. Anticancer research. 2024. 44. 3. 879-888
2023/08 - Annals of Nuclear Medicine Frequently Cited Paper Award High detection rate in [F-18]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients
2023/06 - SNMMI ERF-SNMMI Annual Meeting Travel Award
2023/06 - SNMMI Masahiro Iio, MD Travel Award
2022/09 - 日本核医学会 久田賞(Annals of Nuclear Medicine論文賞)銅賞 Extended single-dose toxicity study of [ 211 At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer
2022/06 - 米国核医学会 Poster Award (Second Place) - Oncology, Basic, and Translational Targeted alpha therapy using astatine (211At)-labeled PSMA5: a preclinical evaluation as a new novel compound
2019/11 - 日本核医学会 第6回日本核医学会リターニー奨励賞
2019/05 - アジアオセアニア核医学会 年次大会 "6th Rising Nuclear Medicine Professional Challenge" Gold award (1st prize)
2018/11 - 日本核医学会核医学会賞
2018/04 - 大阪大学医学部放射線医学教室同門会優秀論文賞(銀賞)
2015/10 - 第3回国際Medical Olympiad 最優秀賞
2015/03 - 日中核医学交流シンポジウム 優秀ポスター賞
2014/11 - 第11回日本核医学会 研究奨励賞
2013/11 - 第3回核医学定量画像解析研究会 菅野賞(最優秀発表賞)
2013/11 - 日本核医学会 久田賞 (Annals of Nuclear Medicine 論文賞)銀賞
2010/06 - SNMMI2010 優秀ポスター賞
全件表示
所属学会 (7件):
日本医学放射線学会 (日本専門医機構認定放射線科専門医)
, 米国核医学会
, Asia Oceania Federation of Nuclear Medicine and Biology (アジア核医学会専門医)
, 日本脳循環代謝学会
, 日本癌学会
, 日本分子イメージング学会
, 日本核医学会 (日本核医学会専門医・PET核医学認定医)